-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
-
Summary
-
Humacyte, Inc. quarterly/annual Depreciation history and growth rate from Q3 2020 to Q2 2024.
- Humacyte, Inc. Depreciation for the quarter ending June 30, 2024 was $1.3M, a 13.3% decline year-over-year.
- Humacyte, Inc. Depreciation for the twelve months ending June 30, 2024 was $5.18M, a 16.3% decline year-over-year.
- Humacyte, Inc. annual Depreciation for 2023 was $5.66M, a 8% decline from 2022.
- Humacyte, Inc. annual Depreciation for 2022 was $6.15M, a 0.49% decline from 2021.
- Humacyte, Inc. annual Depreciation for 2021 was $6.18M, a 1.75% decline from 2020.
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)